Article Details

A Breakthrough in Targeted Cancer Therapy: Lixte Biotechnology Clinical Stage Compound LB-100

Retrieved on: 2021-06-03 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

A Breakthrough in Targeted Cancer Therapy: Lixte Biotechnology Clinical Stage Compound LB-100. View article details on hiswai:

Excerpt

Lixte Biotechnology (NASDAQ: LIXT), a drug discovery company, created and patented a series of novel drugs that enhance the effectiveness of ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up